6568 POSTER Phase II trial of the novel epothilone ZK-EPO as second-line therapy in patients with stage IIIB or stage IV non-small-cell lung cancer

2007 ◽  
Vol 5 (4) ◽  
pp. 378 ◽  
Author(s):  
U. Gatzemeier ◽  
J. vonPawel ◽  
C. Eschbach ◽  
A. Brune ◽  
A. Wagner ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Stage Iv ◽  
Small Cell ◽  
The Novel ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy

Phase II study of cabazitaxel as second-line therapy in stage IV non-small cell lung cancer (NSCLC).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. e19107-e19107
Author(s):  
Devika Das ◽  
Francisco Robert ◽  
Rodolfo Bordoni ◽  
Stefan C. Grant ◽  
Mansoor N. Saleh ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Stage Iv ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy

scholarly journals Phase II Trial of S-1 as Second-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer

2011 ◽  
Vol 6 (4) ◽  
pp. 790-795 ◽  
Author(s):  
Ramaswamy Govindan ◽  
Daniel Morgensztern ◽  
Michael D. Kommor ◽  
Roy S. Herbst ◽  
Paul Schaefer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy

P-3 A phase II trial of the combination of temozolomide and irinotecan as second-line therapy for patients with non-small cell lung cancer

Lung Cancer ◽  
2003 ◽  
Vol 41 ◽  
pp. S91-S92
Author(s):  
Jerome D. Winegarden ◽  
Charles M. Rudin ◽  
Ann M. Mauer ◽  
Philip Hoffman ◽  
Livia Szeto ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document